media age.house News The media arm of age.house, bringing the best in longevity from our community of founders, creators and scientists. https://media.age.house en-US Fri, 10 Jul 2026 00:00:00 GMT © 2026 AGE.HOUSE https://media.age.house/publisher-logo.png media age.house https://media.age.house <![CDATA[Functional-Drinks Brand Reformed Raises $22M Series A to Enter the US]]> https://media.age.house/article/business/functional-drinks-brand-reformed-raises-22m-series-a-to-enter-the-us/ https://media.age.house/article/business/functional-drinks-brand-reformed-raises-22m-series-a-to-enter-the-us/ The UK startup turns instant coffee and matcha into functional-wellness products — with collagen, creatine, and mushrooms mixed in. Two years in, it says it's already at ~$70M in annual revenue.

Read the full article on media.age.house

]]> Fri, 10 Jul 2026 00:00:00 GMT <![CDATA[Anthropic Launches "Claude Science," an AI Workbench Aimed at Biology and Drug Discovery]]> https://media.age.house/article/lifespan/anthropic-launches-claude-science-an-ai-workbench-aimed-at-biology-and-drug-discovery/ https://media.age.house/article/lifespan/anthropic-launches-claude-science-an-ai-workbench-aimed-at-biology-and-drug-discovery/ The company behind Claude has released a research environment that pulls genomics, proteomics, and cheminformatics tools into one place — and is offering academic labs up to $30,000 in credits to try it.

Read the full article on media.age.house

]]> Wed, 01 Jul 2026 00:00:00 GMT <![CDATA[Anodyne Nanotech Raises $12.6M Series A to Take a Once-Weekly GLP-1 Patch into Human Trials]]> https://media.age.house/article/business/anodyne-nanotech-raises-12-6m-series-a-to-take-a-once-weekly-glp-1-patch-into-human-trials/ https://media.age.house/article/business/anodyne-nanotech-raises-12-6m-series-a-to-take-a-once-weekly-glp-1-patch-into-human-trials/ The Boston biotech wants to replace the GLP-1 injection with a room-temperature patch — no needles, no cold storage. Its Series A funds the first clinical test of that idea.

Read the full article on media.age.house

]]> Tue, 30 Jun 2026 00:00:00 GMT <![CDATA[Neko Health Adds Body Composition and Wearables to Its Full-Body Scan]]> https://media.age.house/article/healthspan/neko-health-adds-body-composition-and-wearables-to-its-full-body-scan/ https://media.age.house/article/healthspan/neko-health-adds-body-composition-and-wearables-to-its-full-body-scan/ The preventive-health company co-founded by Spotify's Daniel Ek is now measuring visceral fat and pulling in Apple Health data, pushing its one-hour scan further into everyday health tracking as it prepares to enter the US.

Read the full article on media.age.house

]]> Sat, 27 Jun 2026 00:00:00 GMT <![CDATA[A new syndicate, Peers Capital, launches to fund preventive health at the earliest stage]]> https://media.age.house/article/business/a-new-syndicate-peers-capital-launches-to-fund-preventive-health-at-the-earliest-stage/ https://media.age.house/article/business/a-new-syndicate-peers-capital-launches-to-fund-preventive-health-at-the-earliest-stage/ The investor group is backing pre-seed and seed founders across diagnostics, recovery, and longevity through a deal-by-deal model — and they have already closed its first investments

Read the full article on media.age.house

]]> Fri, 26 Jun 2026 00:00:00 GMT <![CDATA[Insilico Medicine Signs AI Drug-Discovery Deal With SK Biopharmaceuticals Worth Up to $2.5 Billion]]> https://media.age.house/article/business/insilico-medicine-signs-ai-drug-discovery-deal-with-sk-biopharmaceuticals-worth-up-to-2-5-billion/ https://media.age.house/article/business/insilico-medicine-signs-ai-drug-discovery-deal-with-sk-biopharmaceuticals-worth-up-to-2-5-billion/ The AI-driven biotech will run target-to-candidate discovery for neuroimmune disorders, while its Korean partner takes the molecules through late-stage development - Insilico's largest potential deal in Asia-Pacific to date.

Read the full article on media.age.house

]]> Wed, 24 Jun 2026 00:00:00 GMT <![CDATA[Midjourney Launches a Medical Division and a 60-Second Full-Body Scanner]]> https://media.age.house/article/healthspan/midjourney-launches-a-medical-division-and-a-60-second-full-body-scanner/ https://media.age.house/article/healthspan/midjourney-launches-a-medical-division-and-a-60-second-full-body-scanner/ The AI image company is moving into healthcare with "Midjourney Medical" — an ultrasonic whole-body scanner it plans to offer through its own wellness spas rather than clinics, starting in San Francisco in 2027.

Read the full article on media.age.house

]]> Sat, 20 Jun 2026 00:00:00 GMT <![CDATA[Life Biosciences Doses First Patient in Landmark Trial of Cellular-Reprogramming Therapy for Vision Loss]]> https://media.age.house/article/lifespan/life-biosciences-doses-first-patient-in-landmark-trial-of-cellular-reprogramming-therapy-for-vision-loss/ https://media.age.house/article/lifespan/life-biosciences-doses-first-patient-in-landmark-trial-of-cellular-reprogramming-therapy-for-vision-loss/ ER-100 is one of the first attempts to take partial epigenetic reprogramming — resetting cells to a "younger" state — from the lab into a human trial. The first patient has now been dosed.

Read the full article on media.age.house

]]> Wed, 10 Jun 2026 00:00:00 GMT <![CDATA[Longevity advocates to rally in 15 cities, demanding governments treat aging as a medical emergency]]> https://media.age.house/article/lifespan/longevity-advocates-to-rally-in-15-cities-demanding-governments-treat-aging-as-a-medical-emergency/ https://media.age.house/article/lifespan/longevity-advocates-to-rally-in-15-cities-demanding-governments-treat-aging-as-a-medical-emergency/ The April 8 coordinated action calls for dedicated public funding and a regulatory pathway for anti-aging therapies, two things that currently do not exist anywhere in the world.

Read the full article on media.age.house

]]> Mon, 06 Apr 2026 00:00:00 GMT